C-11-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

J.O. Rinne, D.J. Brooks, M.N. Rossor, N.C. Fox, R. Bullock, W.E. Klunk, C.A. Mathis, K. Blennow, J. Barakos, A.A. Okello, S.R.M. de Llano, E. Liu, M. Koller, K.M. Gregg, D. Schenk, R. Black, M. Grundman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)363-372
JournalLancet Neurology
Issue number4
Publication statusPublished - 2010

Cite this